Saint Luke's Newsroom

Saint Luke's News: Dr. Kim Smolderen of Saint Luke’s Mid America Heart Institute Elected Fellow of the American Heart Association
Dr. Kim Smolderen, cardiologist and outcomes research scientist at Saint Luke’s Mid America Heart Institute, has been elected as a Fellow of the American Heart Association by the Council on Peripheral Vascular Disease.
FOX4: Metro mother warns others of vaping dangers after son's hospitalization
A local mom is raising money for Teens Against Vaping after her son was hospitalized at Saint Luke's with serious injuries.
KMBC: Saint Luke's South Hospital NICU graduate is "Going Mahomes"
Saint Luke's South Hospital is celebrating one of its NICU graduates "Going Mahomes" with a special jersey to mark the exciting occasion.
KCTV: More people are surviving lung cancer in the U.S.
While lung cancer remains the leading cause of cancer deaths in the U.S., a new report found more people are surviving the cancer than 10 years ago. KCTV talked to Dr. Subramanian about why it's often still caught in later stages and how one local woman found out she had the disease.
Better Kansas City: Saint Luke's Crittenton Children's Center's Adopt-An-Angel program helps hundreds of children celebrate the holidays
Although the holidays can be a very difficult time for many Crittenton youth, the Adopt-An-Angel program provides positive remembrances and gifts for children who otherwise wouldn’t enjoy the holiday season this way.  
WWII Veteran Returns to Active Lifestyle After Heart Valve Procedure
When Dale Cooksey's mitral valve wasn't sealing normally, doctors at Saint Luke's Mid America Heart Institute performed the MitraClip procedure to get the 98-year-old back to his active lifestyle quickly.
Kansas City Star: KC area woman gets 'breakthrough' drug warding off one of deadliest forms of cancer
New clinical trials are causing a stir of excitement and hope in ovarian cancer circles. The Kansas City Star talked to Dr. Michelle Rowland and Nita Jestila about the treatment that's significantly reducing recurrence in more women.